Takeda Pharmaceutical Co., Ltd. (TAK)
16.04
-0.12
(-0.77%)
USD |
NYSE |
Jan 20, 10:03
Takeda Pharmaceutical EPS Diluted (Quarterly): -0.0253 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 2.020 |
| Pfizer Inc. | 0.6197 |
| Sanofi | -- |
| Nxera Pharma Co., Ltd. | -0.1253 |
| Protagonist Therapeutics, Inc. | -0.6169 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.53M |
| Revenue (Quarterly) | 7.546B |
| Total Expenses (Quarterly) | 7.626B |
| Enterprise Value | 77.88B |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -1.05% |
| Earnings Yield | 0.49% |
| Operating Earnings Yield | 6.41% |
| Normalized Earnings Yield | 1.164 |